Eight Gene Biomarkers Linked to Skin Pore Enlargement
Researchers have identified specific genetic pathways that drive sebum production and the development of visible pores.
Updated on Sept. 24, 2026 in Life Sciences

Scientists have identified eight distinct gene biomarkers associated with sebum production, pore enlargement, and comedogenesis through RNA sequencing analysis. This research marks a step in defining the previously poorly understood molecular mechanisms of skin pore phenotypes.
Why it matters
Understanding these genetic drivers provides a foundation for addressing the molecular pathways underlying common skin pore issues. This work helps clarify the roles of immune-inflammatory and extracellular matrix remodeling in skin physiology.
The study utilized RNA sequencing on four participant groups to isolate eight specific biomarkers, including EXOC3 and TGFA for sebum production, and ALOX5, RIPOR2, and ITGA2 for pore enlargement. These findings correlate specific gene expression levels with physiological skin phenotypes.
The players
Researchers
The scientific team that conducted the comparative RNA sequencing study to isolate genetic markers for skin sebum and pore phenotypes.
The details
Researchers utilized RNA sequencing, a technique that maps the transcriptome to identify which genes are active, to compare samples from four groups ranging from dry skin to oily skin with comedones. Using Spearman correlation analysis, they linked gene expression to physiological metrics, identifying immune-inflammatory and extracellular matrix remodeling pathways as primary drivers. Specifically, the team found that the genes BMP4, TENT5A, and CD28 correlate with comedogenesis, the process of pore clogging.
Timeline
September 24, 2026: The research findings were published.
The Tech Race
This study follows a pattern set by ongoing efforts to map the human skin transcriptome by isolating the specific genetic causes of visible skin characteristics. It advances the field beyond general observations toward the identification of targetable molecular pathways in dermatology.
This research is currently in the discovery phase and does not yet change existing clinical or over-the-counter skincare protocols. Future applications may include targeted treatments that address these specific genetic biomarkers to influence sebum production and pore size.
The takeaway
The study provides a new molecular map of the genes responsible for skin texture and oil production. Watch for follow-up research investigating whether clinical therapies can effectively target these identified immune-inflammatory and extracellular matrix pathways.
Further reading
For more research on skin-related genomic developments, explore the Life Sciences archives.
Source note: This article includes information reported by Nature.






